Oral Dose Of Remdesivir To Soon Hit Markets: Research

Gilead Sciences, the developers of Remdesivir, promising treatment against Covid-19, created a modified version of the medicine. The company, as per reports, has partnered with researchers at Georgia State University, where they have found the medicine to be highly effective in surpassing SARS-CoV-2 replication and transmission in animals when given orally. "It would be groundbreaking in improving patient access to treatment early after infection", said Giorgia State University.